Bring New Treatments to Cancer Patients
with the National Foundation for Cancer Research
Thanks to a generous grant partner, the National Foundation for Cancer Research has recently expanded one of our research focus areas showing tremendous and promising benefits for patients – Circulating Tumor Cell (CTC) research. CTCs shed from the primary tumor enter the bloodstream – and present the risk of metastasis – the cause of 90% of cancer deaths. When captured from a blood sample, CTCs can be used in genomic testing and screened for treatments. Expanded CTC research could improve treatment plans for patients on a personalized level. NFCR’s grant enables us to onboard four new researchers working in this field, but we want to double that.
YOU can help bring new treatment options to cancer patients. Give Today >>>
Doubling the number of researchers means we may be able to deliver new treatment options to cancer patients more quickly. And time is critical to cancer patients waiting for a breakthrough to save their lives. Your support is the missing link to accomplish this. Please, make a generous contribution today to help accelerate breakthrough discoveries in CTC research for many types of cancer..